What risk to the newborn is associated with co-trimoxazole infusion near the time of delivery?

Co-trimoxazole infusion given to the mother near delivery may precipitate or worsen neonatal hyperbilirubinaemia, with a theoretical risk of kernicterus, particularly in infants already at increased risk, such as premature infants and those with glucose-6-phosphate dehydrogenase deficiency.